Healthy men help scientists measure drug absorption in Early-Stage trial
NCT ID NCT05707403
First seen Dec 08, 2025 · Last updated Apr 25, 2026 · Updated 22 times
Summary
This completed Phase 1 trial studied how the experimental drug BI 1015550 is absorbed when taken as a tablet. Eight healthy men received both an oral tablet and a tiny intravenous radioactive tracer dose. The goal was to measure the drug's bioavailability — how much reaches the bloodstream — to guide future development.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.